参考文献/References:
[1] 黄春洋,陈杰,张小丹,等.临床诊断的肝细胞型急性药物性肝损伤患者血清ALT/ALP比值变化特点与组织病理学特征分析[J].实用肝脏病杂志,2021,24(3):379-382.
[2] 张海丛,郭立杰,王超,等.不同种类药物所致药物性肝损伤临床特点研究[J].临床误诊误治,2019,32(1):39-44.
[3] CHEN S N,TAN Y,XIAO X C,et al.Deletion of tlr4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis[J].Acta Pharmacol Sin,2021,42(10):1610-1619.
[4] 张晓倩,杨慧,孟蝶,等.急性药物性肝损伤患者血清中核因子E2相关因子2和血红素加氧酶-1的含量及临床意义[J].胃肠病学和肝病学杂志,2020,29(5):571-575.
[5] 周天慧,莫瑞东,黄燕,等.药物性肝损伤患者血清脂肪酸结合蛋白FABP4水平变化及其临床意义[J].肝脏,2020,25(2):158-161.
[6] 李梁,陶应敏,张学敏,等.药物性肝损伤患者外周血清HIF-1α和COX-2定量检测的临床价值[J].肝脏,2020,25(8):848-852.
[7] 雷晓红,李静,唐洁婷,等.EASL临床实践指南简介:药物性肝损伤[J].肝脏,2019,24(4):339-348.
[8] HASSAN A,FONTANA R J.The diagnosis and management of idiosyncratic drug-induced liver injury[J].Liver Int,2019,39(1):31-41.
[9] 段昕妤,吴凯,朱超慧,等.还原型谷胱甘肽联合多烯磷脂酰胆碱对急性药物性肝损伤患者肝功能、肝纤维化指标及血清炎性因子的影响[J].现代生物医学进展,2021,21(14):2679-2682.
[10] 雷玲,闵珺,刘锋,等.黄芪对肝纤维化大鼠肝损伤保护作用及机制研究[J].陕西中医,2020,41(9):1192-1196.
[11] 孙丽梅,闫惠平,娄金丽,等.抗线粒体抗体M2亚型在药物性肝损伤与原发性胆汁性胆管炎患者中血清学特点分析[J].中华肝脏病杂志,2019,27(4):298-303.
[12] 迟旭,漆沄,陈娟,等.初次抗结核治疗诱发药物性肝损伤临床特点及发病危险因素的Logistic回归分析[J].陕西医学杂志,2019,48(1):67-70.
[13] HOU X,LIU Q,GAO Y,et al.Mesencephalic astrocyte-derived neurotrophic factor reprograms macrophages to ameliorate acetaminophen-induced acute liver injury via p38 Mapk pathway[J].Cell Death Dis,2022,13(2):100-105.
[14] 杨雪,涂荣芳,杨晋辉.498例药物性肝损伤患者的临床特点及其预后分析[J].中华肝脏病杂志,2022,30(7):735-740.
[15] 李玲,何小琪,高勇,等.孕期药物性肝损伤患者血清miR-21、Nrf2和HO-1水平变化及其临床意义探讨[J].实用肝脏病杂志,2023,26(5):662-665.
[16] WANG C,LIU T,TONG Y,et al.Ulinastatin protects against acetaminophen-induced liver injury by alleviating ferroptosis via the sirt1/Nrf2/Ho-1 pathway[J].Am J Transl Res,2021,13(6):6031-6042.
[17] GAO Z,YI W,TANG J,et al.Urolithin a protects against acetaminophen-induced liver injury in mice via sustained activation of Nrf2[J].Int J Biol Sci,2022,18(5):2146-2162.
[18] 杨洋,宋千黛,赵婧瑶,等.Nrf2/HO-1和Smad通路在HIRI介导肝纤维化早期形成的作用[J].中国老年学杂志,2023,43(3):598-602.
[19] ZHANG X,DONG Z,FAN H,et al.Scutellarin prevents acute alcohol-induced liver injury via inhibiting oxidative stress by regulating the Nrf2/Ho-1 pathway and inhibiting inflammation by regulating the Akt,p38 mapk/nf-κb pathways[J].J Zhejiang Univ Sci B,2023,24(7):617-631.
[20] 马成,杨慧.核因子E2相关因子2/血红素加氧酶-1(Nrf2/HO-1)信号通路在酒精性肝病中的作用[J].临床肝胆病杂志,2023,39(7):1708-1713.
[21] 邓梅,李桂忠,谢琳,等.脂肪酸结合蛋白4在同型半胱氨酸致肝细胞脂质沉积中的作用[J].宁夏医科大学学报,2020,42(6):541-546.
[22] HUBEL E,FISHMAN S,HOLOPAINEN M,et al.Repetitive amiodarone administration causes liver damage via adipose tissue er stress-dependent lipolysis,leading to hepatotoxic free fatty acid accumulation[J].Am J Physiol Gastrointest Liver Physiol,2021,321(3):298-307.
[23] ZHAO L,ZHAO J,GAO R,et al.Intrabody against prolyl hydroxylase 2 ameliorates acetaminophen-induced acute liver injury in mice via concomitant promotion of angiogenesis and redox homeostasis[J].Biomed Pharmacother,2020,123(1):109783.
[24] TANG L,WANG F,XIAO L,et al.Yi-qi-jian-pi formula modulates the pi3k/Akt signaling pathway to attenuate acute-on-chronic liver failure by suppressing hypoxic injury and apoptosis in vivo and in vitro[J].J Ethnopharmacol,2021,280(15):114411-114414.
[25] MENISY G M,ZAKARIA S,SUDDEK G M.Nilotinib alleviated acetaminophen-induced acute hepatic injury in mice through inhibiting hif-1alpha/vegf-signaling pathway[J].Int Immunopharmacol,2022,112(1):109268-109269.